SCN1B intron 3 retention results in a nonsense-mediated decay–sensitive mRNA linked to developmental and epileptic encephalopathy
Biallelic variants in the voltage-gated sodium channel (VGSC) gene SCN1B are linked to developmental and epileptic encephalopathy type 52 (DEE52). SCN1B encodes two isoforms: transmembrane β1, generated by all 6 coding exons, and β1B, generated by exons 1 to 3 followed by retention of intron 3 ( SCN1B -IR). Transmembrane β1 subunits are multifunctional proteins that regulate sodium current and channel cell-surface expression, participate in cell–cell and cell–matrix adhesion, and modulate transcription. Several DEE52 variants in the transmembrane β1 coding region have been shown to result in mixed loss-of-function. DEE52 variants are also identified in SCN1B -IR, yet their functional impacts remain unknown. Here, we provide evidence that SCN1B -IR is a cell type–specific, nonsense-mediated decay (NMD)–sensitive transcript. We investigate a severe biallelic DEE52 patient variant in intron 3, SCN1B c.449-2A>G, which results in expression of SCN1B -IR, but not transmembrane β1 transcripts. A transgenic mouse model that expresses SCN1B -IR, but not transmembrane β1, transcript phenocopies Scn1b null mice with seizures and early death. Thus, SCN1B -IR functions as an NMD-sensitive transcript that cannot compensate for the loss of transmembrane β1. We propose that future work may reveal SCN1B -IR to be a therapeutic target similar to other NMD-targeted transcripts.
Authors
- Louis T. Dang (ORCID: https://orcid.org/0000-0003-4853-4952)
- Luis Félix López-Santiago (ORCID: https://orcid.org/0000-0001-6471-4529)
- Annapurna Poduri (ORCID: https://orcid.org/0000-0002-7350-5136)
- Isha Verma (ORCID: https://orcid.org/0000-0002-8024-0164)
- Christelle Moufawad El Achkar (ORCID: https://orcid.org/0000-0003-0497-8172)
- Jack M. Parent (ORCID: https://orcid.org/0000-0002-2972-1528)
- Shreeya Bakshi (ORCID: https://orcid.org/0000-0001-7709-7558)
- Kyle Stokes (ORCID: https://orcid.org/0000-0002-7084-6859)
- Amanda M. Catalfio (ORCID: https://orcid.org/0000-0002-0411-6292)
- Lori L. Isom (ORCID: https://orcid.org/0000-0002-9479-6729)
- Joe Minton
- Chunling Chen (ORCID: https://orcid.org/0009-0005-3169-6324)
- Daniel S. Seagull (ORCID: https://orcid.org/0009-0006-7611-1956)
- Sahana Macedo
- Aazif Hussein
- Yukun Yuan
- Chloe Moore
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- University of Michigan (US)
- VA Ann Arbor Healthcare System (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1073/pnas.2531330123
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Michigan
- National Institutes of Health